Kessler Topaz Meltzer & Explore, LLP Reminds APLT Shareholders of Deadline for Securities Fraud Class Action Lawsuit Filed Against Applied Therapeutics, Inc. (APLT)
RADNOR, PA. – (NewMediaWire) – December 26, 2024 – The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Applied Therapeutics (NASDAQ:), Inc. (Applied Therapeutics) (NASDAQ: APLT) on behalf of those who purchased or acquired Applied Therapeutics Securities between January 3, 2024, and December 2, 2024, inclusive (Class Period). The lead applicant deadline is February 18, 2025.
CONTACT KESSLER TOPAZ MELTZER & HLOLA, LLP:
If you are missing Applied Therapeutics, YOU CAN CLICK HERE or copy and paste the following link into your browser:
You can contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at info@ktmc.com.
COMPLAINTS ALLEGED CONDUCT:
The Complaint alleges that, during the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that Applied Therapeutics was not in compliance with research regulations and good clinical practices for its drug candidate, govorestat, which was developed. a very serious risk that the trial data will be rejected by the FDA in the context of the New Drug Program.
LEAD COMPLAINT PROCEDURE:
Applied Therapeutics investors, no later than February 18, 2025, may seek to be appointed as lead class plaintiff representative by Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to remain inactive and remain a non-class member. The lead plaintiff is the organization representing all the members of the class directing the lawsuit. The lead plaintiff is usually an investor or a small group of investors who have a significant financial interest and are sufficient and unusual in the proposed class of investors. The lead plaintiff selects an attorney to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class attorneys. Your ability to participate in any recovery is not affected by whether or not you serve as the lead plaintiff.
Kessler Topaz Meltzer & Check, LLP encourages investors of Applied Therapeutics who lost significantly to contact the company directly for more information.
CLICK HERE TO FILE A CASE OR GO TO:
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in federal and state courts across the country and around the world. The company has built a global reputation for excellence and has recovered billions of dollars from victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and neglect of businesses and trusts. An appeal in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.
CONTACT:
Kessler Topaz Meltzer & Explore, LLP
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
info@ktmc.com
It may be considered a proxy for advertising in certain areas. Past results do not guarantee future results.
Watch the original release at www.newmediawire.com
Copyright 2024 JCN Newswire. All rights reserved.
